Literature DB >> 17299089

Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets.

John W Semple1, Rukhsana Aslam, Michael Kim, Edwin R Speck, John Freedman.   

Abstract

Platelets express Toll-like receptor 4 (TLR4), and this has been shown to be responsible for the thrombocytopenia induced by lipopolysaccharide (LPS) administration in vivo. We studied the role of LPS in mediating platelet phagocytosis by THP-1 cells in vitro by flow cytometry. Opsonization of platelets with an IgG monoclonal (W6/32) antibody or with IgG autoantibody-positive sera from patients with autoimmune thrombocytopenia (AITP) significantly enhanced platelet phagocytosis (P < .001). In contrast, platelet phagocytosis did not occur if platelets were bound with only LPS. If, however, the LPS-bound platelets were also opsonized with either W6/32 or autoantibody-positive sera with titers greater than 4, there was a significant and synergistic increase in Fc-dependent platelet phagocytosis (P < .001, P = .003, P = .048, and P = .047). These results suggest that, in the presence of antiplatelet antibodies, bacterial products can significantly alter platelet phagocytosis, and this may have relevance to how Gram-negative infections enhance platelet destruction in some patients with AITP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299089     DOI: 10.1182/blood-2006-12-062695

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.

Authors:  Guoying Zhang; Jingyan Han; Emily J Welch; Richard D Ye; Tatyana A Voyno-Yasenetskaya; Asrar B Malik; Xiaoping Du; Zhenyu Li
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

Review 2.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

Review 3.  Platelets and innate immunity.

Authors:  John W Semple; John Freedman
Journal:  Cell Mol Life Sci       Date:  2009-12-18       Impact factor: 9.261

Review 4.  Platelets and the immune continuum.

Authors:  John W Semple; Joseph E Italiano; John Freedman
Journal:  Nat Rev Immunol       Date:  2011-04       Impact factor: 53.106

5.  Platelets from WAS patients show an increased susceptibility to ex vivo phagocytosis.

Authors:  Amanda Prislovsky; Xueying Zeng; Robert A Sokolic; Elizabeth N Garabedian; Praveen Anur; Fabio Candotti; Ted S Strom
Journal:  Platelets       Date:  2012-07-19       Impact factor: 3.862

Review 6.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

7.  Platelets as immune-sensing cells.

Authors:  Rick Kapur; John W Semple
Journal:  Blood Adv       Date:  2016-11-22

Review 8.  The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases.

Authors:  Myrthe E Sonneveld; C Ellen van der Schoot; Gestur Vidarsson
Journal:  J Clin Immunol       Date:  2016-03-10       Impact factor: 8.317

Review 9.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

Review 10.  Platelets as cellular effectors of inflammation in vascular diseases.

Authors:  Matthew T Rondina; Andrew S Weyrich; Guy A Zimmerman
Journal:  Circ Res       Date:  2013-05-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.